Skip to main content
SpringerLink
Log in

Oxidant–Antioxidant Balance in Patients with COPD

  • Published:
Lung Aims and scope Submit manuscript

Abstract

The goal of this study was to evaluate the role of oxidant–antioxidant balance in the pathogenesis of COPD. We included 30 healthy nonsmokers [24 male, 6 female; mean age (yr) ± SD: 62.4 ± 9.3], 30 healthy smokers [27 male, 3 female; mean age (yr) ± SD: 58.7 ± 6.0], 71 patients with stable COPD [68 male, 3 female; mean age (yr) ± SD: 63.5 ± 7.9], and 31 patients with COPD exacerbation [30 male, 1 female; mean age (yr) ± SD: 64.2 ± 7.3]. In all study groups the peripheral venous blood samples were taken for plasma malonyldialdehyde (MDA), a parameter of lipid peroxidation caused by the oxidants, and erythrocyte superoxide dismutase (SOD), an antioxidant enzyme. The mean plasma MDA level was higher in healthy smokers and in patients with COPD than in healthy nonsmokers (p < 0.05), and erythrocyte SOD enzyme activity in patients with COPD exacerbation (1048.2 ± 226.5 Ug/Hb) was significantly higher than in healthy nonsmokers (947.9 ± 198.0 Ug/Hb) (p < 0.05). Although mean erythrocyte SOD enzyme activity in healthy smokers and patients with stable COPD was higher than in healthy nonsmokers, the difference was not statistically significant. We found that healthy smokers and stable and exacerbated COPD patients had an impairment in oxidant–antioxidant balance. We suggested that new therapeutic interventions, which may repair the impaired oxidant-antioxidant balance in COPD, are needed to prevent the development of COPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

Reference

  1. Anthonisen N.R, Manfreda J, Warren W (1987) Antibiotics therapy in exacerbations of chronic obstructive pulmonary disease. Ann Int Med 106:196–204

    CAS  PubMed  Google Scholar 

  2. Cahkoglu M, Unlu A, Tamer L (2002) The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease. Clin Chem Lab Med 40(10):1028–1031

    Google Scholar 

  3. Daga M, Chhabra R, Sharma B (2003) Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci 28:7–11

    CAS  PubMed  Google Scholar 

  4. Hackett NR, Heguy A, Harvey BG (2003) Variability of anti-oxidant related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 29:331–343

    Article  CAS  PubMed  Google Scholar 

  5. Kinnula V, Crapo J (2003) Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167:1600–1619

    Article  PubMed  Google Scholar 

  6. Kocyigit A, Erel O, Gur S (2001) Effects of tobacco smoking on plasma selenium, zinc, copper and iron concentrations and related antioxidative enzyme activities. Clin Biochem 34:629–633

    CAS  PubMed  Google Scholar 

  7. Kurys E, Kurys P, Kuzniar A (2001) Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease. Ann Univ Mariae Curie Sklodowska 56:261–266

    CAS  Google Scholar 

  8. MacNee W, Rahman I (1999) Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:S58–S65

    CAS  PubMed  Google Scholar 

  9. McCord JM, Fridovich I (1969) Superoxide dismutase: An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049–6055

    CAS  PubMed  Google Scholar 

  10. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358

    Article  CAS  PubMed  Google Scholar 

  11. Paredi P, Kharitonov S, Leak D (2000) Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstrucitve pulmonary disease. Am J Respir Crit Care Med 162:369–373

    CAS  PubMed  Google Scholar 

  12. Pratico D, Basili S, Vieri M (1998) Chronic obstructive pulmonary disease is associated with an increase in uriniary levels of isoprostane F2α–III, an index of oxidative stress. Am J Respir Crit Care Med 158:1709–1714

    CAS  PubMed  Google Scholar 

  13. Rahman I, MacNee W (1996) Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 51:348–350

    CAS  PubMed  Google Scholar 

  14. Rahman I, Morrison D, Donaldson K (1996) Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154:1055–1060

    CAS  PubMed  Google Scholar 

  15. Rahman I, Skwarska E, MacNee W (1997) Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52:565–568

    CAS  PubMed  Google Scholar 

  16. Rahman I, Swarska E, Henry M (2000) Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55:189–193

    Article  CAS  PubMed  Google Scholar 

  17. Repine J, Bast A, Lankhorst I (1997) Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:341–357

    CAS  PubMed  Google Scholar 

  18. Yildiz L, Kayaoglu N, Aksoy H (2002) The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers. Clin Chem Lab Med 40(6):612–615

    Article  CAS  PubMed  Google Scholar 

  19. Zhou JF, Yan XF, Guo FZ (2000) Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci 13(1):44–55

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Disease, School of Medicine, Cukurova University, 01330, Balcali, Adana, Turkey

    Ismail Hanta, Ali Kocabas & Sedat Kuleci

  2. Department of Biochemistry, School of Medicine, Cukurova University, 01330, Balcali, Adana, Turkey

    Necmiye Canacankatan

  3. Department of Biostatistics, School of Medicine, Cukurova University, 01330, Balcali, Adana, Turkey

    Gulsah Seydaoglu

Authors
  1. Ismail Hanta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Kocabas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Necmiye Canacankatan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sedat Kuleci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gulsah Seydaoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ismail Hanta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanta, I., Kocabas, A., Canacankatan, N. et al. Oxidant–Antioxidant Balance in Patients with COPD. Lung 184, 51–55 (2006). https://doi.org/10.1007/s00408-005-2561-4

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-005-2561-4

Keywords

Search

Navigation